Skip to content

Acetic acid chromoendoscopy for detection of neoplastic Barrett's esophagus

Acetic acid chromoendoscopy for detection of neoplastic Barrett's esophagus

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON25059
Enrollment
3268
Registered
2019-12-04
Start date
2020-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Barrett's esophagus

Interventions

Sponsors

St. Antonius Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - 18 years of age or older - Diagnosis of Barrett’s esophagus undergoing surveillance gastroscopy - Signed consent for the use of patient data

Exclusion criteria

Exclusion criteria: - Previous treatment for esophageal neoplasia (endoscopic resection, photodynamic therapy, argon plasma coagulation, radiofrequency ablation) - Referral from other centers with suspected or known dysplasia for assessment and endoscopic intervention - Obvious visible cancers at gastroscopy other than esophageal adenocarcinoma (i.e. gastric cancer, or esophageal squamous cell carcinoma) - Known dysplasia or intensified endoscopic surveillance because of previously diagnosed dysplasia - Prior esophagectomy - Active esophagitis LA grade C or higher, precluding endoscopic biopsies (patients can be included after adequate treatment) - Esophageal varices precluding endoscopic biopsies - Coagulation disorders precluding endoscopic biopsies - Allergy to acetic acid

Design outcomes

Primary

MeasureTime frame
Overall neoplasia detection rate (defined as the percentage of patients with either targeted or standardized random biopsies containing LGD, HGD or EAC).

Secondary

MeasureTime frame
1. Neoplasia detection rate stratified by degree of neoplasia in biopsies (LGD, HGD, EAC). 2. Neoplasia detection rate in of targeted biopsies only (defined as the percentage of patients with targeted biopsies containing LGD, HGD and EAC). 3. Duration of endoscopy.

Contacts

Public ContactIlse Beaufort

St. Antonius Ziekenhuis

i.beaufort@antoniusziekenhuis.nl088-3206043

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)